Literature DB >> 24502306

Efficacy of treatment with oral alitretinoin in patient suffering from lichen simplex chronicus and severe atopic dermatitis of hands.

Angelo Massimiliano D'Erme1, Nicola Milanesi, Arianna Fay Agnoletti, Vincenza Maio, Daniela Massi, Massimo Gola.   

Abstract

Lichen simplex chronicus (LSC) is a skin disorder characterized by chronic itching and scratching, which can lead to thick, leathery, brownish skin, sometimes with papules and can be associated with atopic eczema. We report the case of a 52-year-old man with a 45-year atopic condition and presenting LSC in his dorsum. After a 3-month treatment with alitretinoin at the daily dosage of 30 mg, we have observed a moderate improvement of the hand eczema together with a substantial clinical improvement of LSC and an almost complete resolution of pruritus. We want to report this peculiar case to suggest the use of oral alitretinoin for LSC.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  alitretinoin; atopic dermatitis; lichen simplex chronicus

Mesh:

Substances:

Year:  2013        PMID: 24502306     DOI: 10.1111/dth.12035

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  4 in total

1.  Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment.

Authors:  Jung Eun Kim; Hyun Jeong Kim; Bark-Lynn Lew; Kyung Ho Lee; Seung Phil Hong; Yong Hyun Jang; Kui Young Park; Seong Jun Seo; Jung Min Bae; Eung Ho Choi; Ki Beom Suhr; Seung Chul Lee; Hyun Chang Ko; Young Lip Park; Sang Wook Son; Young Jun Seo; Yang Won Lee; Sang Hyun Cho; Chun Wook Park; Joo Young Roh
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

Review 2.  Systemic Treatment of Adult Atopic Dermatitis: A Review.

Authors:  Matteo Megna; Maddalena Napolitano; Cataldo Patruno; Alessia Villani; Anna Balato; Giuseppe Monfrecola; Fabio Ayala; Nicola Balato
Journal:  Dermatol Ther (Heidelb)       Date:  2016-12-26

3.  Alitretinoin in Dermatology-An Update.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

Review 4.  [Recommendations when switching therapy from immunosuppressive drugs to dupilumab in patients with atopic dermatitis].

Authors:  Johannes Wohlrab; Ulrich Mrowietz; Stephan Weidinger; Thomas Werfel; Andreas Wollenberg
Journal:  Hautarzt       Date:  2021-04       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.